Massachusetts House and Senate Come Together to “Screen at 23”

Joint Resolution Calls on the State’s Public Health System and Providers to Use BMI 23 When Screening Asian Americans for Diabetes Boston, MA – (January 22, 2018) – Legislators from both the...
Read more on Massachusetts House and Senate Come Together to “Screen at 23”

EMTs Not Allowed to Administer Glucagon

EMTs Not Allowed to Administer Glucagon

A new paper co-authored by Joslin’s CMO Robert A. Gabbay, MD, PhD finds administration of life-saving medicine not in scope of practice for EMTs Boston, MA—(January 16, 2018) — For people with...
Read more on EMTs Not Allowed to Administer Glucagon

Trial Suggests Way to Personalize Heart Health in Diabetes

Genetic analysis links the hormone GLP-1 with cardiovascular mortality risks. BOSTON – (November 29, 2017) – Scientists at Joslin Diabetes Center have taken another step toward solving a long-standing...
Read more on Trial Suggests Way to Personalize Heart Health in Diabetes

Different Sugars, Different Risks to Your Liver

Studies in mice show that fructose plays a more damaging role than glucose in fatty liver disease and help to explain why. BOSTON – (October 3, 2017) – If you’re one of the two billion people in the...
Read more on Different Sugars, Different Risks to Your Liver

Finding A Natural Defense against Clogged Arteries

Research in mice highlights protective mechanism that lowers chronic inflammation leading toward cardiovascular disease. BOSTON – (September 20, 2017) – In type 2 diabetes, chronic inflammation drives...
Read more on Finding A Natural Defense against Clogged Arteries

Joslin Diabetes Center Signs Agreement with China Horae Capital Management Group Co., Ltd.

Alliance will provide expertise and training for new diabetes center in Nanjing, China Boston, Ma. – (September 18, 2017) – Joslin Diabetes Center, the world’s preeminent diabetes care and research...
Read more on Joslin Diabetes Center Signs Agreement with China Horae Capital Management Group Co., Ltd.

George King, MD, Honored at the GK50 Healthcare and Life Sciences

Boston – (September 18, 2017) – George L. King, MD, Senior Vice President and Chief Scientific Officer of Joslin Diabetes Center received the Founders Choice Award during GK50, an event celebrating...
Read more on George King, MD, Honored at the GK50 Healthcare and Life Sciences

Medalist Study Underlines Importance of Blood Glucose Control in Older Adults with Type 1 Diabetes

Better management is linked to lower risks of cardiovascular disease, the leading cause of death in this population. BOSTON – (July 26, 2017) – “People are living longer with type 1 diabetes, and the...
Read more on Medalist Study Underlines Importance of Blood Glucose Control in Older Adults with Type 1 Diabetes

Joslin Diabetes Center Receives $8.4 Million for NIH-Sponsored Diabetes Research Center (DRC) Program

Boston – (July 1, 2017) - Joslin Diabetes Center, the preeminent institution for diabetes research and care, affiliated with Harvard Medical, has been awarded $8.2 million from the National Institutes...
Read more on Joslin Diabetes Center Receives $8.4 Million for NIH-Sponsored Diabetes Research Center (DRC) Program

Institutions to Focus on Improving Type 1 Diabetes Care with Machine Learning

Children’s Mercy Kansas City and Joslin Diabetes Center announce project with Cyft technology to apply predictive analytics to proactively identify and manage at-risk individuals June 9, 2017 –...
Read more on Institutions to Focus on Improving Type 1 Diabetes Care with Machine Learning

Joslin Diabetes Center Creates Center for Cell-Based Therapy for Diabetes (CCTD)

BOSTON, MA (June 8, 2017) – Researchers and clinicians at Joslin Diabetes Center have established a Center for Cell-Based Therapy for Diabetes (CCTD), the goal of which is to lead the development and...
Read more on Joslin Diabetes Center Creates Center for Cell-Based Therapy for Diabetes (CCTD)

Connecting the Dots Between Insulin Resistance, Unhealthy Blood Vessels And Cancer

Animal studies examine risk factors that may overlap between colorectal cancer and cardiovascular disease. BOSTON – (May 1, 2017) – Over the decades, scientists have repeatedly shown that patients...
Read more on Connecting the Dots Between Insulin Resistance, Unhealthy Blood Vessels And Cancer

Forging New Defenses against Diabetic Kidney Disease

Study of Joslin Medalists suggests a novel treatment approach that may protect against dangerous complications. BOSTON – (April 24, 2017) – More than 660,000 people in the United States suffer from...
Read more on Forging New Defenses against Diabetic Kidney Disease

New Test Identifies Patients with Diabetes Who Are At High Risk of Kidney Failure

BOSTON – (April 18, 2017) - Researchers from Joslin Diabetes Center have developed a prognostic tool that accurately predicts the risk of end stage renal disease (ESRD) in patients with both type 1...
Read more on New Test Identifies Patients with Diabetes Who Are At High Risk of Kidney Failure

To make an adult care appointment, call 617-309-2400 or make an appointment online.